AGF Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
AGF Management's REGN Position: Q2 2026 in Review
AGF Management increased its Regeneron Pharmaceuticals (REGN) stake by 1,061% in Q2 2026, buying an estimated $3M and bringing the position to 4,819 shares worth $3M. The position accounts for 0.01% of the portfolio, ranked #390.
AGF Management first reported a position in REGN in Q4 2022 and has held it in 12 quarters since. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- AGF Management held 4,819 shares of Regeneron Pharmaceuticals worth $3M as of Q2 2026.
- AGF Management bought 4,404 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $3M.
- Regeneron Pharmaceuticals made up 0.01% of AGF Management's portfolio in Q2 2026, its #390 holding.
- AGF Management first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 12 quarters since.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on AGF Management's 13F filing for Q2 2026, filed 10 Aug 2026.